1. Home
  2. AMPH vs CCB Comparison

AMPH vs CCB Comparison

Compare AMPH & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CCB
  • Stock Information
  • Founded
  • AMPH 1996
  • CCB 1997
  • Country
  • AMPH United States
  • CCB United States
  • Employees
  • AMPH N/A
  • CCB N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CCB Major Banks
  • Sector
  • AMPH Health Care
  • CCB Finance
  • Exchange
  • AMPH Nasdaq
  • CCB Nasdaq
  • Market Cap
  • AMPH 1.1B
  • CCB 1.5B
  • IPO Year
  • AMPH 2014
  • CCB 2018
  • Fundamental
  • Price
  • AMPH $21.34
  • CCB $99.52
  • Analyst Decision
  • AMPH Hold
  • CCB Strong Buy
  • Analyst Count
  • AMPH 5
  • CCB 3
  • Target Price
  • AMPH $38.00
  • CCB $105.00
  • AVG Volume (30 Days)
  • AMPH 448.1K
  • CCB 120.8K
  • Earning Date
  • AMPH 08-07-2025
  • CCB 07-29-2025
  • Dividend Yield
  • AMPH N/A
  • CCB N/A
  • EPS Growth
  • AMPH N/A
  • CCB 17.19
  • EPS
  • AMPH 2.77
  • CCB 3.22
  • Revenue
  • AMPH $730,659,000.00
  • CCB $335,549,000.00
  • Revenue This Year
  • AMPH $0.92
  • CCB $109.11
  • Revenue Next Year
  • AMPH $5.55
  • CCB $36.30
  • P/E Ratio
  • AMPH $7.84
  • CCB $30.54
  • Revenue Growth
  • AMPH 8.05
  • CCB 28.09
  • 52 Week Low
  • AMPH $20.43
  • CCB $45.92
  • 52 Week High
  • AMPH $53.96
  • CCB $106.38
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 38.79
  • CCB 52.49
  • Support Level
  • AMPH $20.43
  • CCB $91.25
  • Resistance Level
  • AMPH $22.90
  • CCB $103.87
  • Average True Range (ATR)
  • AMPH 0.73
  • CCB 3.42
  • MACD
  • AMPH 0.11
  • CCB -0.73
  • Stochastic Oscillator
  • AMPH 36.84
  • CCB 65.53

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

Share on Social Networks: